Mutational Analysis of Lck in CD45-Negative T Cells: Dominant Role of Tyrosine 394 Phosphorylation in Kinase Activity

REFERENCES

• Abraham, N., M. C. Miceli, J. R. Parnes, A. Veillette, and S. Abbot. 1991. Enhancement of T-cell responsiveness by the lymphocyte-specific tyrosine protein kinase p56lck. Nature (London) 350:62–66.
   PubMedGoogle Scholar
• Amrein, K. E., and B. M. Sefton. 1988. Mutation of a site of tyrosine phosphorylation in the lymphocyte-specific tyrosine protein kinase, p56lck, reveals its oncogenic potential in fibroblasts. Proc. Natl. Acad. Sci. USA 85:4247–4251.
   PubMed Web of Science ®Google Scholar
• Appleby, M. W., J. A. Gross, M. P. Cooke, S. D. Levin, X. Qian, and R. M. Perlmutter. 1992. Defective T cell receptor signaling in mice lacking the thymic isoform of p59fyn. Cell 70:751–763.
   PubMedGoogle Scholar
• Bei, R., J. Kantor, S. V. Kashmiri, and J. Schlom. 1994. Serological and biochemical characterization of recombinant baculovirus carcinoembryonic antigen. Mol. Immunol. 3102:771–780.
   Google Scholar
• Bennett, B. D., S. Cowley, S. Jiang, R. London, B. Deng, J. Grabarek, J. E. Groopman, D. V. Goeddel, and H. Avraham. 1994. Identification and characterization of a novel tyrosine kinase from megakaryocytes. J. Biol. Chem. 269:1068–1074.
   PubMed Web of Science ®Google Scholar
• Bergman, M., T. Mustelin, C. Oetken, J. Partanen, N. A. Flint, K. E. Amrein, M. Autero, P. Burn, and K. Alitalo. 1992. The human p50csk tyrosine kinase phosphorylates p56lck at Tyr-505 and down regulates its catalytic activity. EMBO J. 11:2919–2924.
   PubMed Web of Science ®Google Scholar
• Boyle, W. J., P. van der Geer, and T. Hunter. 1991. Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Methods Enzymol. 201:110–152.
   PubMed Web of Science ®Google Scholar
• Burns, C. M., K. Sakaguchi, E. Appella, and J. D. Ashwell. 1994. CD45 regulation of tyrosine phosphorylation and enzyme activity of src family kinases. J. Biol. Chem. 269:13594–13600.
   PubMedGoogle Scholar
• Cheng, H. C., H. Nishio, O. Hatase, S. Ralph, and J. H. Wang. 1992. A synthetic peptide derived from p34cdc2 is a specific and efficient substrate of src-family tyrosine kinases. J. Biol. Chem. 267:9248–9256.
   PubMedGoogle Scholar
• Cooke, M. P., K. M. Abraham, K. A. Forbush, and R. M. Perlmutter. 1991. Regulation of T cell receptor signaling by a src family protein-tyrosine kinase (p59fyn). Cell 65:281–291.
   PubMed Web of Science ®Google Scholar
• Couture, C., G. Baier, C. Oetken, S. Williams, D. Telford, A. Marie-Cardine, G. Baier-Bitterlich, S. Fischer, P. Burn, A. Altman, and T. Mustelin. 1994. Activation of p56lck by p72syk through physical association and N-terminal tyrosine phosphorylation. Mol. Cell. Biol. 14:5249–5258.
   PubMedGoogle Scholar
• Danielian, S., A. Alcover, L. Polissard, M. Stefanescu, O. Acuto, S. Fischer, and R. Fagard. 1992. Both T cell receptor (TcR)-CD3 complex and CD2 increase the tyrosine kinase activity of p56lck. CD2 can mediate TcR-CD3-independent and CD45-dependent activation of p56lck. Eur. J. Immunol. 22:2915–2921.
   PubMed Web of Science ®Google Scholar
• Deans, J. P., S. B. Kammer, R. M. Torres, and J. A. Ledbetter. 1992. Interaction of CD4:lck with the T cell receptor/CD3 complex induces early signaling events in the absence of CD45 tyrosine phosphatase. Eur. J. Immunol. 22:661–668.
   PubMedGoogle Scholar
• Desai, D. M., J. Sap, O. Silvennoinen, J. Schlessinger, and A. Weiss. 1994. The catalytic activity of the CD45 membrane-proximal phosphatase domain is required for TCR signaling and regulation. EMBO J. 13:4002–4010.
   PubMedGoogle Scholar
• Evan, G. I., G. K. Lewis, G. Ramsay, and J. M. Bishop. 1985. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol. Cell. Biol. 5:3610–3616.
   PubMed Web of Science ®Google Scholar
• Glaichenhaus, N., N. Shastri, D. R. Littman, and J. M. Turner. 1991. Re- quirement for association of p56lck with CD4 in antigen-specific signal trans-duction in T cells. Cell 64:511–520.
   PubMed Web of Science ®Google Scholar
• Imamoto, A., and P. Soriano. 1993. Disruption of the csk gene, encoding a negative regulator of Src family tyrosine kinases, leads to neural tube defects and embryonic lethality in mice. Cell 73:1117–1124.
   PubMed Web of Science ®Google Scholar
• Imbert, V., D. Farahifar, P. Auberger, D. Mary, B. Rossi, and J.-F. Peyron. 1996. Stimulation of the T-cell antigen receptor-CD3 complex signaling pathway by the tyrosine phosphatase inhibitor pervanadate is mediated by inhibition of CD45: evidence for two interconnected Lck-Fyn- or Zap-70-dependent signaling pathways. J. Inflamm. 46:65–77.
   PubMedGoogle Scholar
• Johansen, T. E., M. S. Scholler, S. Tolstoy, and T. W. Schwartz. 1990. Biosynthesis of peptide precursors and protease inhibitors using new constitutive and inducible eukaryotic expression vectors. FEBS Lett. 267:289–294.
   PubMed Web of Science ®Google Scholar
• June, C. H., M. C. Fletcher, J. A. Ledbetter, and L. E. Samelson. 1990. Increases in tyrosine phosphorylation are detectable before phospholipase C activation after T cell receptor stimulation. J. Immunol. 144:1591–1599.
   PubMed Web of Science ®Google Scholar
• June, C. H., M. C. Fletcher, J. A. Ledbetter, G. L. Schieven, J. N. Siegel, A. F. Phillips, and L. E. Samelson. 1990. Inhibition of tyrosine phosphorylation prevents T-cell receptor-mediated signal transduction. Proc. Natl. Acad. Sci. USA 87:7722–7726.
   PubMed Web of Science ®Google Scholar
• Karnitz, L., S. L. Sutor, T. Torigoe, J. C. Reed, M. P. Bell, D. J. McKean, P. J. Leibson, and R. T. Abraham. 1992. Effects of p56lck deficiency on the growth and cytolytic effector function of an interleukin-2-dependent cyto-toxic T-cell line. Mol. Cell. Biol. 12:4521–4530.
   PubMedGoogle Scholar
• Klages, S., D. Adam, K. Class, J. Fargnoli, J. B. Bolen, and R. C. Penhallow. 1994. Ctk: a protein-tyrosine kinase related to Csk that defines an enzyme family. Proc. Natl. Acad. Sci. USA 91:2597–2601.
   PubMed Web of Science ®Google Scholar
• Koretzky, G. A., J. Picus, T. Schultz, and A. Weiss. 1991. Tyrosine phos-phatase CD45 is required for T-cell antigen receptor and CD2-mediated activation of a protein tyrosine kinase and interleukin 2 production. Proc. Natl. Acad. Sci. USA 88:2037–2041.
   PubMedGoogle Scholar
• Koretzky, G. A., J. Picus, M. L. Thomas, and A. Weiss. 1990. Tyrosine phosphatase CD45 is essential for coupling T-cell antigen receptor to the phosphatidyl inositol pathway. Nature (London) 346:66–68.
   PubMed Web of Science ®Google Scholar
• Marth, J. D., J. A. Cooper, C. S. King, S. F. Ziegler, D. A. Tinker, R. W. Overell, E. G. Krebs, and R. M. Perlmutter. 1988. Neoplastic transformation induced by an activated lymphocyte-specific protein tyrosine kinase (pp56lck). Mol. Cell. Biol. 8:540–550.
   PubMed Web of Science ®Google Scholar
• McFarland, E. D., T. R. Hurley, J. T. Pingel, B. M. Sefton, A. Shaw, and M. L. Thomas. 1993. Correlation between Src family member regulation by the protein-tyrosine-phosphatase CD45 and transmembrane signaling through the T-cell receptor. Proc. Natl. Acad. Sci. USA 90:1402–1406.
   PubMed Web of Science ®Google Scholar
• Molina, T. J., K. Kishihara, D. P. Siderovski, W. van Ewijk, A. Narendran, E. Timms, A. Wakeham, C. J. Paige, K.-U. Hartmann, A. Veillette, D. Davidson, and T. W. Mak. 1992. Profound block in thymocyte development in mice lacking p56lck. Nature (London) 357:161–164.
   PubMed Web of Science ®Google Scholar
• Murphy, S. M., M. Bergman, and D. O. Morgan. 1993. Suppression of c-Src activity by C-terminal Src kinase involves the c-Src SH2 and SH3 domains: analysis with Saccharomyces cerevisiae. Mol. Cell. Biol. 13:5290–5300.
   PubMedGoogle Scholar
• Mustelin, T., and A. Altman. 1990. Dephosphorylation and activation of the T cell tyrosine kinase pp56lck by the leukocyte common antigen (CD45). Oncogene 5:809–813.
   PubMed Web of Science ®Google Scholar
• Mustelin, T., K. M. Coggeshall, and A. Altman. 1989. Rapid activation of the T-cell tyrosine protein kinase pp56lck by the CD45 phosphotyrosine phos-phatase. Proc. Natl. Acad. Sci. USA 86:6302–6306.
   PubMed Web of Science ®Google Scholar
• Mustelin, T., T. Pessa-Morikawa, M. Autero, M. Gassmann, L. C. Anders-son, C. G. Gahmberg, and P. Burn. 1992. Regulation of the p59fyn protein tyrosine kinase by the CD45 phosphotyrosine phosphatase. Eur. J. Immunol. 22:1173–1178.
   PubMed Web of Science ®Google Scholar
• Nada, S., M. Okada, A. MacAuley, J. A. Cooper, and H. Nakagawa. 1991. Cloning of a complementary DNA for a protein-tyrosine kinase that specifically phosphorylates a negative regulatory site of p60c-src. Nature (London) 351:69–72.
   PubMed Web of Science ®Google Scholar
• Niklinska, B. B., D. Hou, C. June, A. M. Weissman, and J. D. Ashwell. 1994. CD45 tyrosine phosphatase activity and membrane anchoring are required for T-cell antigen receptor signaling. Mol. Cell. Biol. 14:8078–8084.
   PubMedGoogle Scholar
• Okada, M., S. Nada, Y. Yamanashi, T. Yamamoto, and H. Nakagawa. 1991. CSK: a protein-tyrosine kinase involved in regulation of src family kinases. J. Biol. Chem. 266:24249–24252.
   PubMed Web of Science ®Google Scholar
• Ostergaard, H. L., D. A. Shackelford, T. R. Hurley, P. Johnson, R. Hyman, B. M. Sefton, and I. S. Trowbridge. 1989. Expression of CD45 alters phosphorylation of the lck-encoded tyrosine protein kinase in murine lymphoma T-cell lines. Proc. Natl. Acad. Sci. USA 86:8959–8963.
   PubMed Web of Science ®Google Scholar
• Ostergaard, H. L., and I. S. Trowbridge. 1990. Coclustering CD45 with CD4 or CD8 alters the phosphorylation and kinase activity of p56lck. J. Exp. Med. 172:347–350.
   PubMed Web of Science ®Google Scholar
• Roussel, R. R., S. R. Brodeur, D. Shalloway, and A. P. Laudano. 1991. Selective binding of activated pp60c- src by an immobilized synthetic phos-phopeptide modeled on the carboxyl terminus of pp60c- src. Proc. Natl. Acad. Sci. USA 88:10696–10700.
   PubMedGoogle Scholar
• Samelson, L. E., A. F. Phillips, E. T. Luong, and R. D. Klausner. 1990. Association of the fyn protein-tyrosine kinase with the T-cell antigen receptor. Proc. Natl. Acad. Sci. USA 87:4358–4362.
   PubMed Web of Science ®Google Scholar
• Sieh, M., J. B. Bolen, and A. Weiss. 1993. CD45 specifically modulates binding of Lck to a phosphopeptide encompassing the negative regulatory tyrosine of Lck. EMBO J. 12:315–321.
   PubMedGoogle Scholar
• Stein, P. L., H.-M. Lee, S. Rich, and P. Soriano. 1992. pp59fyn mutant mice display differential signaling in thymocytes and peripheral T cells. Cell 70:741–750.
   PubMed Web of Science ®Google Scholar
• Straus, D. B., and A. Weiss. 1992. Genetic evidence for the involvement of the ick tyrosine kinase in signal transduction through the T cell antigen receptor. Cell 70:585–593.
   PubMed Web of Science ®Google Scholar
• Tsygankov, A. Y., B. M. Broker, J. Fargnoli, J. A. Ledbetter, and J. B. Bolen. 1992. Activation of tyrosine kinase p60fyn following T cell antigen receptor cross-linking. J. Biol. Chem. 267:18259–18262.
   PubMedGoogle Scholar
• Turner, J. M., M. H. Brodsky, B. A. Irving, S. D. Levin, R. M. Perlmutter, and D. R. Littman. 1990. Interaction of the unique N-terminal region of tyrosine kinase p56lck with cytoplasmic domains of CD4 and CD8 is mediated by cysteine motifs. Cell 60:755–765.
   PubMed Web of Science ®Google Scholar
• Veillette, A., J. B. Bolen, and M. A. Bookman. 1989. Alterations in tyrosine protein phosphorylation induced by antibody-mediated cross-linking of the CD4 receptor of T lymphocytes. Mol. Cell. Biol. 9:4441–4447.
   PubMed Web of Science ®Google Scholar
• Veillette, A., M. A. Bookman, E. M. Horak, and J. B. Bolen. 1988. The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck. Cell 55:301–308.
   PubMed Web of Science ®Google Scholar
• Veillette, A., M. A. Bookman, E. M. Horak, L. E. Samelson, and J. B. Bolen. 1989. Signal transduction through the CD4 receptor involves the activation of the internal membrane tyrosine-protein kinase p56lck. Nature (London) 338:257–259.
   PubMed Web of Science ®Google Scholar
• Veillette, A., and M. Fournel. 1990. The CD4 associated tyrosine protein kinase p56lck is positively regulated through its site of autophosphorylation. Oncogene 5:1455–1462.
   PubMedGoogle Scholar
• Volarevic, S., B. B. Niklinska, C. M. Burns, C. H. June, A. M. Weissman, and J. D. Ashwell. 1993. Regulation of TCR signaling by CD45 lacking transmembrane and extracellular domains. Science 260:541–544.
   PubMedGoogle Scholar
• Volarevic, S., B. B. Niklinska, C. M. Burns, H. Yamada, C. H. June, F. J. Dumont, and J. D. Ashwell. 1992. The CD45 tyrosine phosphatase regulates phosphotyrosine homeostasis and its loss reveals a novel pattern of late T cell receptor-induced Ca2+ oscillations. J. Exp. Med. 176:835–844.
   PubMedGoogle Scholar
• Watts, J. D., J. S. Sanghera, S. L. Pelech, and R. Aebersold. 1993. Phosphorylation of serine 59 of p56lck in activated T cells. J. Biol. Chem. 268:23275–23282.
   PubMed Web of Science ®Google Scholar
• Weaver, C. T., J. T. Pingel, J. O. Nelson, and M. L. Thomas. 1991. CD8+ T-cell clones deficient in the expression of the CD45 protein tyrosine phosphatase have impaired responses to T-cell receptor stimuli. Mol. Cell. Biol. 11:4415–4422.
   PubMedGoogle Scholar
• Winkler, D. G., I. Park, T. Kim, N. S. Payne, C. T. Walsh, J. L. Strominger, and J. Shin. 1993. Phosphorylation of Ser-42 and Ser-59 in the N-terminal region of the tyrosine kinase p56lck. Proc. Natl. Acad. Sci. USA 90:5176–5180.
   PubMed Web of Science ®Google Scholar
• Zamoyska, R., P. Derham, S. D. Gorman, P. von Hoegen, J. B. Bolen, A. Veillette, and J. R. Parnes. 1989. Inability of CD8α polypeptides to associate with p56lck correlates with impaired function in vitro and lack of expression in vivo. Nature (London) 342:278–281.
   PubMed Web of Science ®Google Scholar